The $100,000 Taubman Prize For Excellence in Translational Medical Science

Presented every other year by the Taubman Institute at the University of Michigan, this award recognizes the scientist who has done the most to transform laboratory discoveries into clinical applications for patients suffering from disease.

Nominations for the 2021 Taubman Prize will be accepted beginning in November, 2020.

Deadline for submission is February 1, 2021.

Prize: $100,000


  • International scientists are eligible.
  • U-M scientists are excluded.
  • Self-nomination is permitted.
  • The recipient must be available for a two-day visiting professorship in Ann Arbor at a mutually agreeable time

Judging Criteria:

  • Significant contribution to translating basic research findings into medical practice
  • The manner in which nominee’s clinical activities connects to his or her laboratory research


Nomination Guidelines

For a nomination to be considered by the selection committee, the following items must be submitted with the completed nomination form:

  • A one-page letter of nomination detailing the individual’s extraordinary or sustained contribution to the field of translational research
  • The curriculum vitae of the nominee
  • A bibliography of the nominee’s five most significant publications
  • Two additional one-page letters of support

Questions?  Please email or phone (734) 615-7282.

Past Recipients:

2019: Professor Sir Stephen O’Rahilly, MD, Co-Director, Wellcome Trust-MRC Institute of Metabolic Science, Professor of Clinical Biochemistry and Medicine, University of Cambridge, for paradigm-shifting work on the genetic causes of obesity and its adverse effect on metabolic health.

2017: Stephen L. Hauser, M.D., director of the UCSF Weill Institute for Neurosciences and professor and chair of the Department of Neurology at the University of California, San Francisco, for discoveries that paved the way for a highly effective drug in the treatment of MS.

2016: Suzanne L. Topalian, M.D. of Johns Hopkins University School and Jedd D. Wolchok, M.D., Ph.D. of Memorial Sloan Kettering Cancer Center, for their contributions to immunotherapy as a new paradigm in the
treatment of advanced cancers.

2015: Mahlon DeLong, M.D., of Emory University, for his contributions to the treatment of Parkinson’s disease.

2014: Carl June, M.D., of the Perelman School of Medicine at the University of Pennsylvania, for discoveries relatedto immunotherapy for leukemia using patients’ own T cells.

2013: Brian Druker, M.D., of the Oregon Health & Science University and Charles Sawyers, M.D., of Memorial SloanKettering Cancer Center, for their discoveries related to chronic myeloid leukemia.

2012: Hal Dietz, M.D., of Johns Hopkins University for his discoveries related to connective tissue disease.

The following individuals comprise the national selection committee that will judge the entries for the 2019 Taubman Prize:

Garrett Brodeur, M.D.

  • Director of the Cancer Predisposition Program at Children’s Hospital of Pennsylvania
  • Associate Director of the Abramson Cancer Center at Pennsylvania Valerie Opipari, M.D.
  • Chair, Pediatrics and Communicable Diseases, University of Michigan Medical School
  • Ravitz Foundation Professor of Pediatrics and Communicable Diseases
  • Professor of Pediatric Hematology/Oncology

Mahlon DeLong, M.D.

  • William Timmie Professor of Neurology at Emory University School of Medicine
  • Co-Director and Founder of Emory Neuromodulation and Technology Innovation Center
  • 2015 Taubman Prize recipient

Harry Dietz, M.D.

  • Victor A. McKusick Professor of Genetics and Medicine, Johns Hopkins University
  • Howard Huges Medical Institute Investigator
  • 2012 Taubman Prize recipient

Stephen L. Hauser, M.D., Ph.D.

  • Robert A. Fishman Distinguished Professor of Neurology at the University of California, San Francisco.
  • Director, UCSF Weill Institute for Neurosciences
  • 2017 Taubman Prize recipient

Carl H. June, M.D.

  • Richard W. Vague Professor in Immunotherapy, Perelman School of Medicine, University of Pennsylvania
  • 2014 Taubman Prize recipient

William C. Mobley, M.D., Ph.D.

  • Distinguished Professor and Chair, Department of Neurosciences, University of California at San Diego
  • Executive Director, UCSD Down Syndrome Center for Research and Treatment
  • Florence Riford Chair of Alzheimer Disease Research

David C. Page, M.D.

  • Director, Whitehead Institute  Professor of Biology, Massachusetts Institute of Technology
  • Howard Hughes Medical Institute Investigator

Stephen M. Strittmatter, M.D., Ph.D.

  • Vincent Coates Professor of Neurology and Professor of Neurobiology, Yale School of Medicine
  • Director, Cellular Neuroscience, Neurodegeneration and Repair
  • Director, Memory Disorders Clinic
  • Director, Yale Alzheimer’s Disease Research Center